MedSci Healthcare Holdings Limited (HKG:2415)
Hong Kong · Delayed Price · Currency is HKD 0.7600
-0.0050 (-0.65%)
Sep 10, 2026, 4:08 PM HKT
HKG:2415 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 262.58 | 270.37 | 260.62 | 349.19 | 348.95 | 297.73 | |
Revenue Growth | -4.59% | 3.74% | -25.36% | 0.07% | 17.20% | 37.93% |
Cost of Revenue | 118.28 | 109.93 | 98.45 | 132.59 | 142.63 | 107.92 |
Gross Profit | 144.3 | 160.45 | 162.17 | 216.61 | 206.32 | 189.81 |
Selling, General & Admin | 88.48 | 102.68 | 140 | 146.9 | 168.29 | 122.84 |
Research & Development | 25.49 | 30.66 | 23.24 | 39.86 | 35.01 | 24.41 |
Operating Expenses | 129 | 146.76 | 177.26 | 200.35 | 205.85 | 153.67 |
Operating Income | 15.29 | 13.68 | -15.09 | 16.26 | 0.48 | 36.14 |
Interest Expense | -0.63 | -0.22 | -0.15 | -0.28 | -0.36 | -0.27 |
Interest & Investment Income | 8.6 | 8.6 | 16.2 | 15.37 | 10.38 | 4.85 |
Other Non Operating Income (Expenses) | -7.82 | -2.54 | 1.13 | 9.34 | 2.56 | -188.61 |
EBT Excluding Unusual Items | 15.44 | 19.52 | 2.09 | 40.69 | 13.06 | -147.89 |
Gain (Loss) on Sale of Investments | - | - | 23.41 | 6.97 | - | - |
Gain (Loss) on Sale of Assets | - | - | - | - | - | 0.84 |
Other Unusual Items | - | - | - | 12.79 | -109.35 | - |
Pretax Income | 15.44 | 19.52 | 25.5 | 60.45 | -96.29 | -147.06 |
Income Tax Expense | 0.11 | 1.59 | 0.53 | 5.41 | 3.59 | 3.97 |
Net Income | 15.34 | 17.94 | 24.97 | 55.04 | -99.88 | -151.03 |
Net Income to Common | 15.34 | 17.94 | 24.97 | 55.04 | -99.88 | -151.03 |
Net Income Growth | -59.60% | -28.16% | -54.64% | - | - | - |
Shares Outstanding (Basic) | 551 | 548 | 541 | 518 | 473 | 9 |
Shares Outstanding (Diluted) | 551 | 548 | 541 | 519 | 473 | 9 |
Shares Change | 1.88% | 1.29% | 4.23% | 9.74% | 5419.00% | -10.35% |
EPS (Basic) | 0.03 | 0.03 | 0.05 | 0.11 | -0.21 | -17.64 |
EPS (Diluted) | 0.03 | 0.03 | 0.05 | 0.08 | -0.21 | -17.64 |
EPS Growth | -64.32% | -35.05% | -43.31% | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | - | 1.99 | 54.61 | 37.86 | -14.56 | 36.46 |
Free Cash Flow Per Share | - | 0.00 | 0.10 | 0.07 | -0.03 | 4.26 |
Dividend Per Share | - | 0.010 | - | - | - | - |
Dividend Growth | - | - | - | - | - | - |
Gross Margin | 54.95% | 59.34% | 62.23% | 62.03% | 59.13% | 63.75% |
Operating Margin | 5.83% | 5.06% | -5.79% | 4.66% | 0.14% | 12.14% |
Profit Margin | 5.84% | 6.63% | 9.58% | 15.76% | -28.62% | -50.73% |
Free Cash Flow Margin | - | 0.74% | 20.95% | 10.84% | -4.17% | 12.25% |
EBITDA | 16.4 | 14.82 | -14.16 | 17.4 | 1.62 | 37.12 |
EBITDA Margin | 6.25% | 5.48% | -5.44% | 4.98% | 0.46% | 12.47% |
D&A For EBITDA | 1.11 | 1.14 | 0.92 | 1.14 | 1.15 | 0.98 |
EBIT | 15.29 | 13.68 | -15.09 | 16.26 | 0.48 | 36.14 |
EBIT Margin | 5.83% | 5.06% | -5.79% | 4.66% | 0.14% | 12.14% |
Effective Tax Rate | 0.70% | 8.13% | 2.08% | 8.95% | - | - |